Home / World Marketplace / Archive by category Global Health & Biotech (Page 16)

Archive by category Global Health & Biotech

Indonesia’s Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces

July 29, 2025 Long-term multiyear agreements will see Philips installing its advanced Azurion image-guided therapy systems nationwide across all provinces, including rural and remote areas Initiative brings minimally invasive care to millions of cardiac, stroke and cancer patients in Indonesia Combines cutting-edge treatment technology, services and training to strengthen Indonesia’s health infrastructure Amsterdam, the Netherlands [...]

Philips builds strong order intake momentum and drives margin expansion in Q2

July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6% Group sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 bps to 12.4% of sales Free cash flow increased to EUR 230 million Philips increases full year 2025 outlook for Adjusted [...]

Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

Paving the Way for Broader Access and the First Combined CCM®/ICD System MARLTON, N.J., July 28, 2025 (Korea Bizwire) – Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced two major accomplishments, marking an inflection point in the advancement and accessibility of CCM® Therapy. The [...]

Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative

Liminatus Identifies BNB Coin as Its Primary Strategic Target for Digital Asset Allocation, with Plans to Aggressively Accumulate and Hold Up to $500 Million for Long-Term Strategic Value LA PALMA, Calif., July 28, 2025 (Korea Bizwire) – Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today [...]

Boehringer Ingelheim and Re-Vana Therapeutics Announce Strategic Collaboration to Develop Long-Acting Ophthalmic Therapies

● Up to three development programs per year leading to a potential total deal value exceeding $1 billion contingent on milestone achievements. Ingelheim, Germany, Tampa, Florida, USA, and Belfast, Northern Ireland, UK [28 July 2025] – Boehringer Ingelheim and Re-Vana Therapeutics, a US and UK based developer of ocular therapeutics and ocular drug delivery technologies, today announced [...]

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate

Second antibody-drug conjugate (ADC) to progress into clinical development utilizing our proprietary payload and optimized antibody Preclinical results demonstrate strong anti-tumor activity and favorable tolerability profile Phase 1 clinical trial evaluating ZW251 in hepatocellular carcinoma (HCC) expected to be initiated in 2025 VANCOUVER, British Columbia, July 28, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), [...]

Bangladesh Proposes to Ban Safer Nicotine Products Under Foreign Influence, Ignoring Public Health Evidence and Regional Precedents

MANILA, Philippines, July 28, 2025 (Korea Bizwire) – The Bangladesh Ministry of Health is pushing a new tobacco control bill that proposes a sweeping ban on all safer nicotine products (SNPs), including vaping devices and oral alternatives. Alarmingly, this move is being pursued without public consultation and under an interim government—raising serious concerns about transparency [...]

Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health

Sujata Setia, Mithail Afrige Chowdhury and Steve Gschmeissner awarded £10,000 each for images exploring domestic abuse, climate migration and the hidden dangers of cholesterol LONDON, July 25, 2025 (Korea Bizwire) — Wellcome’s 2025 Photography Prize celebrates three image makers whose work reveals the human stories behind science and health. UK-based artist Sujata Setia, Bangladeshi documentary and [...]

First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2

Boehringer Laboratory Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion) Regulatory submissions underway for zongertinib and nerandomilast, with launches expected in H2 2025 Strategic investments in R&D and global manufacturing to drive innovation and support future growth Boehringer Ingelheim, a leading research-driven biopharmaceutical company, reported positive [...]

Kalsec® Inc. Enhances and Rebrands Hops Division to KalHops

Rebrand empowers brewers to “Brew Extraordinary™” with innovative and tailored hops offerings KALAMAZOO, Mich., July 23, 2025 (Korea Bizwire) – Kalsec® Inc., a global natural ingredient solution provider for the food and beverage industry, today announced the relaunch of its hops division under the brand name KalHops. This strategic rebranding affirms Kalsec’s commitment to continued innovation [...]